Cutler Group LP Biomarin Pharmaceutical Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Cutler Group LP holds 2,200 shares of BMRN stock, worth $142,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,200

Previous 8,200 73.17%

Holding current value

$142,736

Previous $70,000 87.14%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$87.74 - $117.27 $118,361 - $158,197	-1,349 Reduced 62.77%	800 $77,000
Q4 2022 Feb 07, 2023	BUY	$80.93 - $108.63 $173,918 - $233,445	2,149 New	2,149 $222,000
Q2 2022 Aug 04, 2022	SELL	$71.48 - $86.85 $5,932 - $7,208	-83 Reduced 3.82%	2,087 $172,000
Q3 2021 Oct 26, 2021	SELL	$74.77 - $85.47 $22,431 - $25,641	-300 Reduced 12.15%	2,170 $167,000
Q2 2021 Jul 19, 2021	BUY	$75.51 - $84.79 $178,958 - $200,952	2,370 Added 2370.0%	2,470 $206,000
Q1 2021 Apr 26, 2021	SELL	$74.73 - $90.69 $405,484 - $492,083	-5,426 Reduced 98.19%	100 $7,000
Q4 2020 Jan 21, 2021	BUY	$72.61 - $90.2 $314,110 - $390,205	4,326 Added 360.5%	5,526 $484,000
Q3 2020 Oct 27, 2020	SELL	$71.87 - $131.03 $57,496 - $104,824	-800 Reduced 40.0%	1,200 $91,000
Q1 2020 May 07, 2020	BUY	$71.37 - $96.85 $7,137 - $9,685	100 Added 5.26%	2,000 $169,000
Q4 2019 Feb 06, 2020	BUY	$64.27 - $86.37 $115,686 - $155,466	1,800 Added 1800.0%	1,900 $160,000
Q3 2019 Oct 28, 2019	SELL	$67.4 - $85.11 $458,320 - $578,748	-6,800 Reduced 98.55%	100 $6,000
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $365,592 - $427,245	4,550 Added 193.62%	6,900 $590,000
Q1 2019 May 10, 2019	SELL	$84.2 - $98.62 $1.53 Million - $1.79 Million	-18,184 Reduced 88.56%	2,350 $208,000
Q4 2018 Feb 05, 2019	BUY	$80.14 - $106.07 $749,148 - $991,542	9,348 Added 83.57%	20,534 $1.75 Million
Q3 2018 Nov 07, 2018	BUY	$93.92 - $105.72 $340,741 - $383,552	3,628 Added 48.0%	11,186 $1.08 Million
Q2 2018 Aug 10, 2018	BUY	$76.01 - $99.03 $73,881 - $96,257	972 Added 14.76%	7,558 $711,000
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $465,010 - $554,575	-5,987 Reduced 47.62%	6,586 $533,000
Q4 2017 Jan 17, 2018	SELL	$80.76 - $95.13 $44,014 - $51,845	-545 Reduced 4.15%	12,573 $1.12 Million
Q3 2017 Oct 17, 2017	BUY	$80.6 - $94.95 $1.06 Million - $1.25 Million	13,118	13,118 $1.22 Million

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account